Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-05-25 @ 11:53 AM
Study NCT ID:
NCT04624633
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-27
First Post:
2020-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
Sponsor:
Jennifer R. Brown, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20-394
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None